Close close

SEARCH

Enter your search term below:

WORLD LEADING BUSINESS SUPPORT

SEARCH RESULTS

1974

New toolkit from SETsquared aims to speed up research commercialisation

News | Nikita Troughton | Thu, 22/05/2025 | 11:33

Investors, university commercialisation teams, and legal professionals gathered in London this week for the launch of Phase 1 of the Deal Readiness Toolkit, a new, open-access resource developed to accelerate and simplify the commercialisation of university research. Created by the SETsquared Partnership, in collaboration with legal experts and investors and funded by Research...

Research impact training – hydrogen

Programme | Emma Blunt | Thu, 22/05/2025 | 09:06

Hydrogen launchpad

Programme | Emma Blunt | Thu, 22/05/2025 | 08:53

Pioneering dual-use technologies for a safer world

Content Page | Emma Blunt | Thu, 22/05/2025 | 08:45

Angel Investing: a front-row seat to the future of innovation

Blog | Roderick Beer | Mon, 19/05/2025 | 15:30

People often ask me, “Why should I become an angel investor?” And after years of working closely with the start-up ecosystem and investing myself, I can tell you, there are countless reasons. From the potential for strong financial returns to the joy of mentoring the next generation of entrepreneurs, angel...

From research to reality: How ICURe empowered Ash Zarkan to launch BioTryp Therapeutics

Blog | Nikita Troughton | Wed, 07/05/2025 | 10:42

Q&A Blog: Insights from Ash Zarkan on the ICURe Engage Programme Introduce yourself and your venture Ash Zarkan: My name is Ash Zarkan. I'm the CEO and co-founder of BioTryp Therapeutics. BioTryp is a spin-out from the University of Cambridge. We are still based in Cambridge, and the science was...

SETsquared is a partnership between

Close close

Mailing List sign-up